BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) Sees Large Decrease in Short Interest

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) was the target of a significant decline in short interest in the month of September. As of September 30th, there was short interest totaling 2,320 shares, a decline of 67.3% from the September 15th total of 7,084 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily volume of 24,423 shares, the short-interest ratio is presently 0.1 days.

BioForce Nanosciences Price Performance

BioForce Nanosciences stock opened at $7.46 on Wednesday. The business has a 50 day simple moving average of $6.21 and a 200-day simple moving average of $2.90. BioForce Nanosciences has a 12 month low of $0.18 and a 12 month high of $10.99. The stock has a market capitalization of $284.00 million, a PE ratio of 746.75 and a beta of 0.63.

BioForce Nanosciences (OTCMKTS:BFNH) last posted its quarterly earnings data on Monday, August 10th. The company reported $0.01 earnings per share for the quarter.

BioForce Nanosciences Company Profile

BioForce Nanosciences, Inc develops nanotechnology tools and systems designed for research in life sciences, materials science and related fields. The company’s technologies are intended to support the controlled manipulation, deposition and analysis of very small quantities of biological and chemical materials.

Its product portfolio has included nanoscale patterning and fluid-handling systems, including the Nano eNabler platform. These tools are designed for applications such as creating biological arrays, depositing samples and reagents, and conducting research involving cells, proteins, DNA and other materials at the micro- and nanoscale.

BioForce Nanosciences was based in the United States and focused primarily on serving scientific, academic and industrial research markets.